Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yuxintine in Major Depressive Disorder
NCT02395263Phase 2Unknown
- Sponsor
- Shanghai Mental Health Center
- Start
- Mar 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of yuxintine in major depressive disorder (MDD), sponsored by Shanghai Mental Health Center. Status: unknown.
02
Drugs
yuxintine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02395263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02395263.